Reduced pteridine derivatives induce apoptosis in human neuronal NT2/HNT cells
N Spöttl1, B Wirleitner, G Böck
1Institut for Medical Chemistry and Biochemistry, University of Innsbruck, Austria.
Immunobiology
|April 25, 2000
Summary
Reduced pteridines, like neopterin, can trigger apoptosis in human neuronal cells, potentially contributing to neurodegenerative diseases. Antioxidants offer partial protection, indicating reactive oxygen species involvement.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Elevated neopterin and 7,8-dihydroneopterin in cerebrospinal fluid are linked to neurodegenerative diseases and CNS infections.
- Pteridines are biologically active compounds with roles in various physiological processes.
Purpose of the Study:
- To investigate the potential of pteridine compounds to induce apoptosis in human neuronal cells.
- To explore the role of reduced versus non-reduced pteridines in neuronal cell survival.
- To determine the involvement of reactive oxygen species in pteridine-induced apoptosis.
Main Methods:
- Culturing and differentiating human neuronal cell line (NT2) into neurons and astrocytes.
- Treating cells with various pteridine derivatives (reduced and non-reduced forms).
- Assessing apoptosis using cell viability assays and detecting reactive oxygen species (ROS) formation.
Main Results:
- Reduced pteridines (neopterin, biopterin, folate derivatives) significantly increased apoptosis in a time-dependent manner.
- Non-reduced pteridines did not substantially affect neuronal cell survival.
- Antioxidants partially protected cells from apoptosis, and ROS production was directly observed, suggesting ROS mediation.
Conclusions:
- High concentrations of reduced pteridines may contribute to neuronal cell loss observed in neurodegenerative conditions.
- The findings highlight a potential mechanism linking pteridine metabolism to neuronal pathology.
- Reactive oxygen intermediates play a role in pteridine-induced neuronal apoptosis.
